Tactile Systems Technology (NASDAQ:TCMD - Get Free Report) will likely be releasing its earnings data after the market closes on Tuesday, February 18th. Analysts expect Tactile Systems Technology to post earnings of $0.31 per share and revenue of $85.39 million for the quarter. Persons that are interested in participating in the company's earnings conference call can do so using this link.
Tactile Systems Technology Stock Up 2.3 %
Shares of TCMD stock traded up $0.39 during mid-day trading on Friday, hitting $17.33. 151,968 shares of the stock traded hands, compared to its average volume of 242,456. The stock has a market cap of $415.87 million, a P/E ratio of 26.66 and a beta of 1.20. The stock's fifty day moving average is $17.49 and its two-hundred day moving average is $15.51. Tactile Systems Technology has a 52-week low of $11.12 and a 52-week high of $21.10. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.37 and a quick ratio of 3.80.
Wall Street Analyst Weigh In
Several equities analysts recently commented on TCMD shares. StockNews.com lowered shares of Tactile Systems Technology from a "strong-buy" rating to a "buy" rating in a research report on Thursday, January 16th. BTIG Research lowered shares of Tactile Systems Technology from a "buy" rating to a "neutral" rating in a research report on Tuesday, November 5th. Finally, Oppenheimer lowered shares of Tactile Systems Technology from an "outperform" rating to a "market perform" rating in a research report on Tuesday, November 5th.
Check Out Our Latest Stock Report on Tactile Systems Technology
About Tactile Systems Technology
(
Get Free Report)
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Recommended Stories
Before you consider Tactile Systems Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tactile Systems Technology wasn't on the list.
While Tactile Systems Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
